申请人:ASTRAZENECA AB
公开号:WO2004089877A1
公开(公告)日:2004-10-21
The present invention relates to new compounds of formula I, [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, R4 and R5 are as defined as in formula I, or salts, solvates or solvated salts thereof, a process for their preparation, pharmaceutical compositions containing said compounds and to the use of said compounds in therapy. The compounds are vanilloid receptor 1 (VR1) inhibitors and are useful in the treatment of a number of different disorders, for example acute and chronic neuropathic and inflammatory pain.
本发明涉及公式I的新化合物,其中R1、R2、R3、R4和R5如公式I中所定义,或其盐、溶剂合物或溶剂化盐,以及它们的制备方法、含有所述化合物的药物组合物以及所述化合物在治疗中的应用。这些化合物是辣椒素受体1(VR1)抑制剂,对于治疗多种不同疾病,例如急性和慢性神经病理性和炎症性疼痛,具有用处。